-
¹ØÓÚÒâ´óÀû¹ó±ö»á¹ÙÍø
-
-
ÐÂÎŶ¯Ì¬
-
-
-
Éç»áÔðÈÎ
-
Ͷ×ÊÕß¹Øϵ
²úÆ·ÖÐÐÄ
ÁªÏµÒâ´óÀû¹ó±ö»á¹ÙÍø
ÏúÊÛרÓãº
µØµã£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
Fmoc Amine PEG Amine, TFA Salt
²úÆ·´úºÅ£º
FMOC-PEG-NH2TFA
²úÆ·´¿¶È£º
¡Ý 95%
°ü×°¹æ¸ñ£º
1g, 10g, 100gµÈ£¨ÌØÊâ°ü×°ÐèÊÕÈ¡·Ö×°Óöȣ©
·Ö×ÓÁ¿£º
2000 Da,3500 Da, 5000 Da, 7500 DaµÈ
Òªº¦´Ê£º
ËùÊô·ÖÀࣺ
¿ÆÑпͻ§Ð¡ÅúÁ¿Ò»¼ü²É¹ºµØµã£¨Ð¡ÓÚ5¿Ë£©
- ²úÆ·ÃèÊö
- ²Î¿¼ÎÄÏ×
-
¡¡¡¡Òâ´óÀû¹ó±ö»á¹ÙÍø¿Æ¼¼Éú²úµÄÒìÜ̼×ÑõôÊ°±»ù¾ÛÒÒ¶þ´¼°·Èý·úÒÒËáÑβúÆ·Öк¬Óа·»ùÍż°Êܱ£»¤µÄ°·»ù£¬Í¨³£ÓÃ×÷Á½ÖÖ²î±ð»¯Ñ§ÎïÖʵĽ»Áª¼Á»ò¼ä¸ôÎï ¡£´ËÒ칦ЧPEGÑÜÉúÎïÖеÄPEG²¿·Ö¿ÉÌṩˮÈÜÐÔ¡¢ÉúÎïÏàÈÝÐÔ¼°ÈáÐÔ ¡£´Ë²úƷרÃÅÓ¦ÓÃÓÚ¿¹ÌåżÁªÒ©Îï(ADC¡¯s)µÄ¿ª·¢ ¡£
²úÆ·±àÂë
²úÆ·´úºÅ
A5138
FMOC-PEG2000-NH2TFA
A5139
FMOC-PEG3500-NH2TFA
A5140
FMOC-PEG5000-NH2TFA
A5141
FMOC-PEG7500-NH2TFA
¡¡¡¡Òâ´óÀû¹ó±ö»á¹ÙÍø¿Æ¼¼ÌṩFMOC-PEG-NH2TFA·Ö×ÓÁ¿2000 Da,3500 Da, 5000 Da, 7500 DaµÄ²úÆ·1¿ËºÍ10¿Ë°ü×° ¡£
¡¡¡¡Òâ´óÀû¹ó±ö»á¹ÙÍø¿Æ¼¼Ìṩ·ÖװЧÀÍ£¬ÐèÒªÊÕÈ¡·Ö×°Óöȣ¬Èç¹ûÄúÐèÒª·ÖװΪÆäËû¹æ¸ñÇëÓëÎÒÃÇÁªÏµ ¡£
¡¡¡¡Òâ´óÀû¹ó±ö»á¹ÙÍø¿Æ¼¼Í¬Ê±ÌṩÆäËû·Ö×ÓÁ¿µÄFMOC-PEG-NH2TFAÑÜÉúÎï²úÆ·£¬ÈçÄãÐèÒªÇëÓëÎÒ˾sales@jenkem.comÁªÏµ ¡£
¡¡¡¡Òâ´óÀû¹ó±ö»á¹ÙÍø¿Æ¼¼Ìṩ´óÅúÁ¿Éú²ú²úÆ·¼°GMP¼¶±ð²úÆ·£¬ÈçÐ豨¼ÛÇëÓëÎÒÃÇÁªÏµ ¡£
-
¡¡¡¡References:
¡¡¡¡1. Soni, K.S., et al., Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer, Journal of Controlled Release, 2017, V. 264, P. 276-287.
¡¡¡¡2. Kim, H.C., et al., Folic Acid-Functionalized Polythiophene for Targeted Cellular Imaging, Journal of Nanoscience and Nanotechnology, 2016, 16:1, p. 189-195(7).
¡¡¡¡3. Fahrländer E., et al., PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent, Nanotechnology, 2015, 26(14):145103.
¡¡¡¡4. Desale, S.S., et al., Targeted delivery of platinum-taxane combination therapy in ovarian cancer, Journal of Controlled Release, 2015, 220B, P. 651-659.
²úƷѯ¼Û
Òâ´óÀû¹ó±ö»á¹ÙÍø
ЧÀÍÈÈÏߣº+86-010-82156767
ÏúÊÛרÓãº+86-010-62983737
²úÆ·×Éѯ£ºsales@jenkem.com
µØµã£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
΢ÐÅÃñÖÚºÅ
΢ÐÅÃñÖÚºÅ